Key terms

About ATAI

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ATAI news

Yesterday 11:35am ET Rising High: Exclusive talk with cannabis market research firm BDSA Apr 17 7:05am ET Atai Life announces publication of Beckley Psytech’s Phase 1 study of BPL-003 Apr 11 10:24am ET Here’s What You Missed in Cannabis, Psychedelics This Week Apr 04 11:06am ET Here’s What You Missed in Cannabis, Psychedelics This Week Apr 03 9:24am ET Maxim upgrades Atai to Buy amid renewed psychedelic interest Apr 03 7:48am ET Atai Life Sciences upgraded to Buy from Hold at Maxim Apr 03 6:59am ET Atai Life Sciences undervalued with catalysts ahead, says Canaccord Apr 03 6:09am ET Atai Life Sciences price target lowered to $15 from $20 at H.C. Wainwright Mar 28 11:32am ET Rising High: Exclusive talk with financial services firm Safe Harbor Financial Mar 28 7:11am ET Atai Life Sciences sees cash runway into 2026 Mar 28 7:10am ET Wall Street Analysts Are Bullish on Top Healthcare Picks Mar 28 7:10am ET Atai Life Sciences reports Q4 EPS (12c), consensus (16c) Mar 27 11:55am ET Buy Rating Affirmed for ATAI Life Sciences on Promising TRD Treatment Trial Outcomes and Strong Valuation Prospects Mar 27 7:12am ET Atai Life announces initial results from Psytech’s Phase 2a study of BPL-003 Mar 21 10:52am ET Here’s What You Missed in Cannabis, Psychedelics This Week Mar 14 11:15am ET Rising High: Exclusive talk with cannabis market research firm BDSA Mar 11 7:53am ET IntelGenx enters amended, restated loan agreement with atai Life Sciences Mar 07 1:09pm ET Rising High: Exclusive talk with multi-state operator C3 Industries Mar 07 10:46am ET Rising High: Exclusive talk with vape tech developer Ispire Technology Mar 04 8:19am ET Atai Life Sciences announces first patint dosed in Phase 1b trial of VLS-01 Feb 29 11:29am ET Here’s What You Missed in Cannabis, Psychedelics This Week Feb 29 11:29am ET Here’s What You Missed in Cannabis, Psychedelics This Week Feb 22 11:19am ET Here’s What You Missed in Cannabis, Psychedelics This Week Feb 22 11:19am ET Here’s What You Missed in Cannabis, Psychedelics This Week Feb 15 10:57am ET Rising High: Exclusive talk with cannabis market research firm BDSA Feb 15 10:57am ET Rising High: Exclusive talk with cannabis market research firm BDSA Feb 08 11:22am ET Rising High: Exclusive talk with house of brands Carma HoldCo Feb 08 11:22am ET Rising High: Exclusive talk with house of brands Carma HoldCo Feb 07 5:14am ET ATAI Life Sciences Signals Executive Shakeup and Strategy Shift Feb 07 5:14am ET ATAI Life Sciences Announces New CFO Appointment and Transition Feb 06 5:01pm ET Atai Life Sciences names Anne Johnson CFO

No recent press releases are available for ATAI

ATAI Financials

1-year income & revenue

Key terms

ATAI Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ATAI Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms